Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells - PubMed (original) (raw)
Comparative Study
. 2006 Dec 15;108(13):4009-17.
doi: 10.1182/blood-2006-04-015024. Epub 2006 Aug 29.
Affiliations
- PMID: 16940422
- DOI: 10.1182/blood-2006-04-015024
Free article
Comparative Study
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells
Silke Holtkamp et al. Blood. 2006.
Free article
Abstract
Adoptive transfer of dendritic cells (DCs) transfected with in vitro-transcribed, RNA-encoding, tumor-associated antigens has recently entered clinical testing as a promising approach for cancer immunotherapy. However, pharmacokinetic exploration of RNA as a potential drug compound and a key aspect of clinical development is still pending. While investigating the impact of different structural modifications of RNA molecules on the kinetics of the encoded protein in DCs, we identified components located 3' of the coding region that contributed to a higher transcript stability and translational efficiency. With the use of quantitative reverse transcription-polymerase chain reaction (RT-PCR) and eGFP variants to measure transcript amounts and protein yield, we showed that a poly(A) tail measuring 120 nucleotides compared with a shorter one, an unmasked poly(A) tail with a free 3' end rather than one extended with unrelated nucleotides, and 2 sequential beta-globin 3' untranslated regions cloned head to tail between the coding region and the poly(A) tail each independently enhanced RNA stability and translational efficiency. Consecutively, the density of antigen-specific peptide/MHC complexes on the transfected cells and their potency to stimulate and expand antigen-specific CD4+ and CD8+ T cells were also increased. In summary, our data provide a strategy for optimizing RNA-transfected DC vaccines and a basis for defining release criteria for such vaccine preparations.
Similar articles
- Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S, Vervaert CE, Burch J Jr, Grichnik J, Seigler HF, Darrow TL. Yang S, et al. Int J Cancer. 1999 Nov 12;83(4):532-40. doi: 10.1002/(sici)1097-0215(19991112)83:4<532::aid-ijc16>3.0.co;2-k. Int J Cancer. 1999. PMID: 10508491 - Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.
Schaft N, Dörrie J, Thumann P, Beck VE, Müller I, Schultz ES, Kämpgen E, Dieckmann D, Schuler G. Schaft N, et al. J Immunol. 2005 Mar 1;174(5):3087-97. doi: 10.4049/jimmunol.174.5.3087. J Immunol. 2005. PMID: 15728524 - Third generation dendritic cell vaccines for tumor immunotherapy.
Frankenberger B, Schendel DJ. Frankenberger B, et al. Eur J Cell Biol. 2012 Jan;91(1):53-8. doi: 10.1016/j.ejcb.2011.01.012. Epub 2011 Mar 25. Eur J Cell Biol. 2012. PMID: 21439674 Review. - mRNA Cancer Vaccines.
Fiedler K, Lazzaro S, Lutz J, Rauch S, Heidenreich R. Fiedler K, et al. Recent Results Cancer Res. 2016;209:61-85. doi: 10.1007/978-3-319-42934-2_5. Recent Results Cancer Res. 2016. PMID: 28101688 Review.
Cited by
- The Recent Research Progress of the Tumor mRNA Vaccine.
Zhao H, Li M, Zhou J, Hu L, Lu S, Li P. Zhao H, et al. Vaccines (Basel). 2024 Oct 12;12(10):1167. doi: 10.3390/vaccines12101167. Vaccines (Basel). 2024. PMID: 39460333 Free PMC article. Review. - Engineering a Novel Modular Adenoviral mRNA Delivery Platform Based on Tag/Catcher Bioconjugation.
Geng K, Rice-Boucher PJ, Kashentseva EA, Dmitriev IP, Lu ZH, Goedegebuure SP, Gillanders WE, Curiel DT. Geng K, et al. Viruses. 2023 Nov 20;15(11):2277. doi: 10.3390/v15112277. Viruses. 2023. PMID: 38005953 Free PMC article. - The dawn of mRNA vaccines: The COVID-19 case.
Verbeke R, Lentacker I, De Smedt SC, Dewitte H. Verbeke R, et al. J Control Release. 2021 May 10;333:511-520. doi: 10.1016/j.jconrel.2021.03.043. Epub 2021 Mar 30. J Control Release. 2021. PMID: 33798667 Free PMC article. Review. - Lipid Nanoparticle Delivery System for mRNA Encoding B7H3-redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors.
Huang C, Duan X, Wang J, Tian Q, Ren Y, Chen K, Zhang Z, Li Y, Feng Y, Zhong K, Wang Y, Zhou L, Guo G, Song X, Tong A. Huang C, et al. Adv Sci (Weinh). 2023 Jan;10(3):e2205532. doi: 10.1002/advs.202205532. Epub 2022 Nov 20. Adv Sci (Weinh). 2023. PMID: 36403209 Free PMC article. - The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.
Mokuda S, Miyazaki T, Ito Y, Yamasaki S, Inoue H, Guo Y, Kong WS, Kanno M, Takasugi K, Sugiyama E, Masumoto J. Mokuda S, et al. Sci Rep. 2015 May 22;5:9795. doi: 10.1038/srep09795. Sci Rep. 2015. PMID: 25997820 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials